Dr. Nishi Bhopal, MD and sleep physician Dr. Audrey Wells, MD discuss why women’s sleep disorders are often missed and walk clinicians through three familiar midlife cases, emphasizing perimenopause/menopause as a window of escalating risk and atypical presentations.
In this interview, Heather Lill from Project Sleep explains the Project Sleep Helpline, a free national resource that helps people and clinicians navigate sleep health questions and sleep disorders by phone, email, or web form. Project Sleep is a 501(c)(3) nonprofit focused on sleep health, sleep equity, and sleep disorder awareness through programs, advocacy training, and resources. Heather describes how the helpline supports anyone at any stage of the diagnostic journey by providing evidence-based information, connecting callers to treatment options, sleep physicians, CBT-I and behavioral sleep medicine directories, patient organizations, support groups, and local resources—especially for those facing barriers to care such as being uninsured or underinsured. She explains follow-up and tracking through a CRM, scope boundaries (not providing medical advice).
Dr. Nishi Bhopal reviews dual orexin receptor antagonists (DORAs)—suvorexant, lemborexant, and daridorexant—explaining how they reduce wake drive by blocking OX1R/OX2R and how this differs from GABAergic hypnotics. She covers dosing timing, food effects, differing half-lives, CYP3A4 interactions, and key adverse effects including sleep paralysis, hypnagogic hallucinations, vivid dreams, next-day sleepiness, and complex sleep behaviors. She argues clinicians are often disappointed when DORAs are expected to fix non-target problems such as circadian disruption, sleep apnea, substance-related sleep fragmentation, or lifestyle-driven hyperarousal, emphasizing accurate insomnia diagnosis using circadian rhythm, sleep drive, and hyperarousal drivers. She highlights best-fit populations (older adults, COMISA, and substance use disorders), discusses longer-term safety data up to 12 months, recommends CBT-I and intermittent dosing to reduce conditioned sleep anxiety, and provides a practical monitoring protocol and medication-selection nuances.
Sleep medicine physician Dr. Michelle Jonelis MD (neurologist background; consults for Fitbit) joins Dr. Nishi Bhopal MD (sleep physician and psychiatrist) to explain how current public sleep messaging can worsen sleep anxiety and insomnia by overemphasizing sleep duration. She reviews prevalence data showing insomnia symptoms are common, many adults worry their sleep is insufficient despite stable short-sleep rates, and many use sleep aids. Dr. Jonelis reframes sleep as a vital sign influenced by internal and external factors, introduces the concept of an individual sleep “set point” that declines with age, and explains rebound sleep after stress or restricted opportunity, which wearables may mistakenly label as “excellent.” She outlines clinician-friendly language shifts (focus on “healthy sleep habits”), discusses normal wakefulness, and presents a practical SLEEPY acronym framework to identify drivers of poor sleep and reduce reliance on full CBTI.
Dr. Nishi Bhopal interviews triple board certified endocrinologist and lifestyle medicine specialist Dr. Chhaya Makhija about how sleep quality and circadian rhythm disruption contribute to insulin resistance, prediabetes, and diabetes via cortisol, adrenaline, growth hormone, and downstream effects on glucose regulation. They outline practical, time-efficient sleep questions clinicians can add to intake (sleep onset/maintenance, regular wake time, daytime sleepiness, snoring/gasping, bedtime routine, supplements, and late eating), discuss why routine cortisol/adrenaline testing is often unhelpful outside conditions like Cushing syndrome, and highlight tools such as HOMA-IR and continuous glucose monitors (Libre and Dexcom) for pattern-based lifestyle coaching. Dr. Makhija shares actionable interventions—post-meal movement, breathwork on waking and at bedtime, and finishing the last meal 3–4 hours before sleep—to reduce glucose excursions and dawn phenomenon, and connects untreated sleep disorders and metabolic dysfunction to erectile dysfunction and secondary hypogonadism, including a basic lab workup for low testosterone.
Dr. Nishi Bhopal explains why insomnia visits often get stuck in a cycle of “sleep effort,” where patients and clinicians try harder, more medications, more strategies, and sleep worsens. She offers a practical framework built around four treatment shifts: stabilize circadian rhythm with daytime anchors (light, movement, consistent meals), rebuild sleep drive by reducing excess time in bed and avoiding early bedtimes that create conditioned arousal, remove common sleep disruptors (alcohol, heavy evening meals, late caffeine, low daytime light, insufficient darkness), and help patients change their relationship with wakefulness by allowing nighttime awakenings without feeding anxiety. She shares patient examples, a swimming analogy for letting sleep happen, and a script for responding to requests for “another sleeping pill,” emphasizing long-term system change and patience over weeks with small consistent adjustments.
Psychiatrist and sleep medicine physician Nishi Bhopal, MD shares a practical clinic workflow to make insomnia evaluations more straightforward, noting most clinicians receive little formal sleep medicine training. Using a case of a woman with refractory insomnia on zolpidem, he shows how missed factors—sleep environment (sleeping in an unventilated closet), undiagnosed obstructive sleep apnea, and behavioral drivers addressed with CBT-I principles like reducing time awake in bed—can lead to major improvement and medication tapering. He teaches a structured framework (FEEM: food, environment, emotional factors, medical conditions), highlights language clues patients use, and explains sleep drive with a hunger analogy. He recommends standardized tools (Epworth, ISI, GAD-7, PHQ-9, MDQ), AASM sleep history/diary, and the patient-centered FIFE interview (feelings, ideas, functioning, expectations) to uncover perpetuating beliefs and the patient’s relationship with sleep.
Psychiatrist and sleep medicine physician Nishi Bhopal, MD explains why chronic insomnia can persist despite sleep hygiene, medications, supplements, melatonin, and even CBT-I, outlining three commonly missed issues in clinical practice: misunderstanding insomnia-related hyperarousal and the patient’s learned relationship with wakefulness at night, the counterproductive effect of trying to force sedation, and targeting the wrong perpetuating factors. Using the 3P model and a case of a 34-year-old tech worker with worsening insomnia, she emphasizes focusing on what perpetuates insomnia rather than what triggered it, introduces the CSH framework (circadian patterns, sleep drive, hyperarousal) to guide targeted, simplified interventions, and highlights how clinician communication and expectations can reduce anxiety and rebuild patient confidence.
Dr. Nishi Bhopal MD, a psychiatrist and sleep medicine physician, explains how to evaluate patients who wake every few hours despite a “normal” sleep study, emphasizing that a single study especially a home sleep apnea test does not rule out sleep apnea or other causes of sleep fragmentation because it mainly measures breathing rather than sleep architecture, limb movements, or narcolepsy. She presents a case where repeated awakenings were driven by upper airway resistance that increased breathing effort and sympathetic activation without meeting apnea criteria. She frames fragmented sleep as recurrent nervous system activations and offers a practical clinical approach: systematically assess four categories of common drivers food/metabolic factors (e.g., reflux, alcohol, hypoglycemia, low ferritin/B12), environmental factors (light, noise, temperature, circadian disruption), emotional/psychological activation (stress, anxiety, rumination, trauma, conditioned arousal), and medical causes (pain, endocrine disorders, RLS/PLMs, sleep apnea, narcolepsy), noting many patients have multiple contributors.
Dr. Bhopal interviews Dr. Amit Chopra, a psychiatrist and sleep specialist at Massachusetts General Hospital and Harvard Medical School, about the bidirectional relationship between major depressive disorder and sleep disorders. Dr. Chopra explains that persistent insomnia increases future depression risk (about twofold overall and nearly fourfold in adolescents), and DSM-5 now treats insomnia as an independent disorder rather than “secondary.” They discuss other common comorbid sleep conditions in depression (obstructive sleep apnea, restless legs syndrome, circadian rhythm disorders, hypersomnolence), consequences of missed diagnoses (recurrence, partial response, treatment resistance), shared neurobiology, and insomnia as an independent suicidality risk factor. The episode outlines a practical 10–15 minute sleep assessment, when to order sleep studies, and evidence-based treatments including CBT-I (techniques, delivery formats, digital options) and selective medication use when needed.
Get high yield sleep medicine tips, strategies, and clinical pearls delivered straight to your email inbox. Every email is also eligible for CMEs. Sign up for “SleepStudy”, my weekly newsletter.
Doctors only get an average of 2 hours of sleep medicine education. Grab this free course to learn what they didn’t teach you in residency…so that you can know exactly what to do to help your patients with sleep disorders (and get free CME).
Recent Comments